Q3 2022 APAC Pharmaceutical Market Intelligence Report

Market Intelligence  •  10 November 2022

The third quarter of 2022 has been an active market for specialist pharmaceutical talent hiring in Asia Pacific. With headcount shortages continuing to plague employers, key players in the industry have gravitated towards alternative ways to secure talent supply. This, of course, has provided candidates a wealth of choice, with considerations stretching beyond the typical realm of tangible compensation.

With the majority of industry turning to contingent hiring to address manpower decline, organisations are already looking to have their budgets to work harder in 2023, with priorities ranging from expanded contingent hiring, infrastructural investment in new territories, and even optimised restructuring efforts to mitigate the problem. What then, can your organisation do to retain the talent required to drive your strategies in 2023 and beyond?

Download our Q3 2022 APAC Pharmaceutical Market Intelligence Report to access expert insights, including:

  • Curated coverage of the quarter’s Pharmaceuticals hiring flux

  • Key recruitment trends in Q3 2022

  • Skills in demand in Pharmaceuticals far this year

  • Industry compensation & benefits trends

  • Talent landscape overviews in the Pharmaceutical, Biotech, and Medical Devices sectors 

Ready to build, re-shape and optimise your workforce for better talent acquisition?

Talk to us